Debevoise & Plimpton is advising Tarsadia Investments on the transaction. Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) announced that it plans to organize and simplify its corporate structure,...
This content is for Standard 1 Year members only. LoginJoin Now